Boothbay Fund Management, LLC Synaptogenix, Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$3.88 - $7.41 $5,071 - $9,684
-1,307 Reduced 8.93%
13,328 $69,000
Q4 2021

Feb 14, 2022
SELL
$8.38 - $13.72 $84,202 - $137,858
-10,048 Reduced 40.71%
14,635 $125,000
Q3 2021

Nov 15, 2021
SELL
$6.65 - $12.1 $62,483 - $113,691
-9,396 Reduced 27.57%
24,683 $245,000
Q2 2021

Aug 16, 2021
BUY
$5.12 - $11.13 $174,484 - $379,299
34,079 New
34,079 $336,000

Others Institutions Holding SNPX

# of Institutions
1
Shares Held
30K
Call Options Held
0
Put Options Held
0
View Full List

About Synaptogenix, Inc.

SNPX Quotes by TradingView
  • Ticker SNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 6,840,630
  • Market Cap $21.2M
  • Description
  • Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...
More about SNPX
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email